Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MDI Launches New Version of Detect-Ready® MRSA Panel at ECCMID

Published: Thursday, September 27, 2012
Last Updated: Thursday, September 27, 2012
Bookmark and Share
Excellent sensitivity of detect-ready panel further strengthened by inclusion of additional MRSA strains.

Molecular Detection Inc. (MDI) has announced that it will release a new version of its Detect-Ready MRSA Panel at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

The superior performance of the Detect-Ready MRSA Panel has been further enhanced by increasing the number of MRSA strains it can detect, adding MRSA strains known to be missed by at least one other market-leading assay to the universe of all known common MRSA strains that were already included.

The new kit also shortens the sample preparation process and minimizes required “hands-on” time.

The Detect-Ready MRSA Panel is a qualitative real-time PCR in vitro diagnostic test. It is CE-marked for the detection of MRSA (methicillin-resistant Staphylococcus aureus) and MSSA (methicillin-sensitive S. aureus) and is the only marketed PCR-based MRSA screening test with the proven ability to discriminate accurately between these pathogens and other related bacteria.

“We are delighted to offer this improved version of the Detect-Ready MRSA Panel to our growing customer base,” commented David Wilson, MDI’s Vice President for Commercial Operations, Europe.

Wilson continued, “The inclusion of additional covered MRSA strains reinforces the superior performance of our existing test, which was recently reconfirmed in an independent comparative study with a market leading competitor. In addition, the simplicity and ease-of-use of Detect-Ready MRSA is further enhanced with our new streamlined protocol for sample prep.”

Comparative data confirming the greater accuracy of the Detect-Ready MRSA panel was generated by researchers at St. Thomas’ Hospital in London as part of an academic study.

The study compared the performance of MDI’s test and the Becton Dickinson GeneOhm MRSA PCR sold by BD Diagnostics.

The researchers concluded that the Detect-Ready MRSA assay is superior to the GeneOhm panel in terms of specificity, while still providing a more rapid screening service compared to traditional microbiology culture methods.

Detect-Ready kits are compatible with a number of the real time-PCR platforms currently found in most hospitals.

Samples for testing are simple to obtain using nasal swabs and the kit’s ready-to-use pre-mixed reagents require only the addition of patient sample to run the test, which provides results in less than three hours.

Unlike other tests that require special handling, Detect-Ready kits are off-the-shelf room temperature-stabilized and require no refrigeration.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!